It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Major 5′terminally deleted (5′TD) group-B enterovirus (EV-B) populations were identified in heart biopsies of patients with fulminant myocarditis or dilated cardiomyopathy suggesting that these 5′TD forms are key drivers of host-cell interaction in EV cardiac infections. To date, early emergence of EV-B 5′TD forms and its impact on type 1 IFN response during acute myocarditis remains unknown. Using quantitative RACE-PCR assay, we identified major EV-B 5′TD RNA populations in plasma or heart samples of acute myocarditis cases. Deletions identified within the 5′ non-coding region of EV-B populations only affected secondary-structural elements of genomic RNA domain I and were distinguished in two major groups based on the extent of RNA structural deletions. Proportions of these two respective EV-B 5′TD population groups were positively or negatively correlated with IFN-β levels in plasma samples of myocarditis patients. Transfection of synthetic CVB3/28 RNAs harboring various 5′terminal full-length or deleted sequences into human cultured cardiomyocytes demonstrated that viral genomic RNA domain I possessed essential immunomodulatory secondary-structural elements responsible for IFN-β pathway induction. Overall, our results highlight the early emergence of major EVB-TD populations which deletions affecting secondary–structures of RNA domain I can modulate innate immune sensing mechanisms in cardiomyocytes of patients with acute myocarditis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Reims Champagne-Ardenne and EA4684 Cardiovir Research Laboratory, Reims, France (GRID:grid.11667.37) (ISNI:0000 0004 1937 0618)
2 University of Reims Champagne-Ardenne and EA4684 Cardiovir Research Laboratory, Reims, France (GRID:grid.11667.37) (ISNI:0000 0004 1937 0618); Centre Hospitalier Universitaire de Reims, Reims, France (GRID:grid.139510.f) (ISNI:0000 0004 0472 3476)
3 National Reference Center of Enterovirus and Parechovirus, Clermont-Ferrand, France (GRID:grid.139510.f); University of Clermont Auvergne, Clermont-Ferrand, France (GRID:grid.494717.8) (ISNI:0000000115480420); Centre Hospitalier Universitaire Clermont-Ferrand, Clermont-Ferrand, France (GRID:grid.411163.0) (ISNI:0000 0004 0639 4151)
4 National Reference Center of Enterovirus and Parechovirus, Clermont-Ferrand, France (GRID:grid.411163.0); University of Clermont Auvergne, Clermont-Ferrand, France (GRID:grid.494717.8) (ISNI:0000000115480420); Centre Hospitalier Universitaire Clermont-Ferrand, Clermont-Ferrand, France (GRID:grid.411163.0) (ISNI:0000 0004 0639 4151)
5 Centre Hospitalier Universitaire de Reims, Reims, France (GRID:grid.139510.f) (ISNI:0000 0004 0472 3476)
6 National Reference Center of Enterovirus and Parechovirus, Lyon, France (GRID:grid.139510.f); Hospices Civils de Lyon, Lyon, France (GRID:grid.413852.9) (ISNI:0000 0001 2163 3825); University of Lyon, Lyon, France (GRID:grid.25697.3f) (ISNI:0000 0001 2172 4233)
7 National Reference Center of Enterovirus and Parechovirus, Lyon, France (GRID:grid.25697.3f); Hospices Civils de Lyon, Lyon, France (GRID:grid.413852.9) (ISNI:0000 0001 2163 3825); University of Lyon, Lyon, France (GRID:grid.25697.3f) (ISNI:0000 0001 2172 4233)
8 Centre Hospitalier Universitaire Clermont-Ferrand, Clermont-Ferrand, France (GRID:grid.411163.0) (ISNI:0000 0004 0639 4151)
9 Hospices Civils de Lyon, Lyon, France (GRID:grid.413852.9) (ISNI:0000 0001 2163 3825)
10 Paris University Hospital, AP-HP, Hôpital Européen Georges Pompidou (HEGP), Paris, France (GRID:grid.50550.35) (ISNI:0000 0001 2175 4109)